- Home
- JZXN vs RANI Comparison
JZXN vs RANI Comparison
Compare JZXN & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZXN
- RANI
- Stock Information
- Founded
- JZXN 2019
- RANI 2012
- Country
- JZXN China
- RANI United States
- Employees
- JZXN N/A
- RANI N/A
- Industry
- JZXN Retail-Auto Dealers and Gas Stations
- RANI Medicinal Chemicals and Botanical Products
- Sector
- JZXN Consumer Discretionary
- RANI Health Care
- Exchange
- JZXN Nasdaq
- RANI Nasdaq
- Market Cap
- JZXN 23.5M
- RANI 24.2M
- IPO Year
- JZXN 2021
- RANI 2021
- Fundamental
- Price
- JZXN $0.37
- RANI $0.50
- Analyst Decision
- JZXN
- RANI Strong Buy
- Analyst Count
- JZXN 0
- RANI 4
- Target Price
- JZXN N/A
- RANI $7.75
- AVG Volume (30 Days)
- JZXN 7.8M
- RANI 266.0K
- Earning Date
- JZXN 03-05-2026
- RANI 11-13-2025
- Dividend Yield
- JZXN N/A
- RANI N/A
- EPS Growth
- JZXN N/A
- RANI N/A
- EPS
- JZXN N/A
- RANI N/A
- Revenue
- JZXN $97,465.00
- RANI $1,200,000.00
- Revenue This Year
- JZXN N/A
- RANI N/A
- Revenue Next Year
- JZXN N/A
- RANI N/A
- P/E Ratio
- JZXN N/A
- RANI N/A
- Revenue Growth
- JZXN N/A
- RANI N/A
- 52 Week Low
- JZXN $0.36
- RANI $0.39
- 52 Week High
- JZXN $7.82
- RANI $3.75
- Technical
- Relative Strength Index (RSI)
- JZXN 33.50
- RANI 47.48
- Support Level
- JZXN $0.40
- RANI $0.49
- Resistance Level
- JZXN $0.48
- RANI $0.53
- Average True Range (ATR)
- JZXN 0.24
- RANI 0.03
- MACD
- JZXN -0.08
- RANI 0.00
- Stochastic Oscillator
- JZXN 0.70
- RANI 40.57
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.